What Researchers Did
Researchers conducted a randomized controlled trial to investigate the therapeutic effects of hyperbaric oxygen therapy added to standard treatment for idiopathic sudden sensorineural hearing loss (ISSHL).
What They Found
Fifty-one hospitalized patients with ISSHL were randomized into two groups: 21 received standard treatment, and 30 received standard treatment plus hyperbaric oxygen (HBO) therapy. Patients receiving HBO therapy showed statistically significant improvement in hearing gains across all frequencies (250, 500, 1,000, 4,000 Hz) except at 2,000 Hz, compared to the standard treatment group.
What This Means for Canadian Patients
Canadian patients experiencing idiopathic sudden sensorineural hearing loss might benefit from hyperbaric oxygen therapy as an adjunct to their standard treatment. This could potentially lead to better hearing recovery, especially if initiated within the first two weeks of onset.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in another country.
Study Limitations
The study's relatively small sample size of 51 patients may limit the generalizability of its findings.